Related Experiment Video

Updated: May 30, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

MAFIP is a tumor suppressor in cervical cancer that inhibits activation of the nuclear factor-kappa B pathway

Yang Li1, Yao Yu, Yan Zhang

  • 1State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China.

Cancer Science
|August 13, 2011
PubMed

Insights

MAFIP acts as a tumor suppressor in cervical cancer by inhibiting the NF-κB pathway. Its downregulation is linked to cervical intraepithelial neoplasia, and restoring MAFIP levels reduces tumor formation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Cervical cancer is a significant global health issue for women.
  • Tumor suppressor gene inactivation is critical in cervical cancer development.
  • Previous research indicated MAFIP inhibits human cervical cancer HeLa cell growth.

Purpose of the Study:

  • To investigate the role of MAFIP as a tumor suppressor in cervical cancer.
  • To elucidate the molecular mechanisms underlying MAFIP's function.
  • To confirm MAFIP's in vivo tumor suppressor activity.

Main Methods:

  • Analyzing MAFIP expression in cervical intraepithelial neoplasia tissues.
  • Inducing MAFIP expression in HeLa cells and assessing tumor formation in nude mice.
  • Evaluating the impact of MAFIP overexpression on the NF-κB signaling pathway components (IKK, IκBα, p65).
  • Assessing the effect of MAFIP on c-myc oncogene induction.
  • Utilizing siRNA to knockdown MAFIP and observe effects on cell proliferation and NF-κB activation.

Main Results:

  • MAFIP expression was found to be downregulated in cervical intraepithelial neoplasia tissues.
  • Induced MAFIP expression significantly inhibited tumor formation in vivo, confirming its tumor suppressor role.
  • Overexpression of MAFIP suppressed NF-κB pathway activation by inhibiting key phosphorylation and degradation events.
  • MAFIP overexpression impaired NF-κB-dependent c-myc induction.
  • MAFIP knockdown activated the NF-κB pathway and promoted cell proliferation.

Conclusions:

  • MAFIP functions as a tumor suppressor in cervical cancer.
  • MAFIP inhibits cervical cancer progression, partly through the suppression of NF-κB pathway activation.
  • MAFIP downregulation is associated with cervical cancer development, suggesting its potential as a therapeutic target.

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...